Blood Flow Restriction Training After Patellar INStability

Study Purpose

This research study is designed to allow health care professionals and researchers to answer many questions about whether a new type of physical therapy called blood flow restriction training (called BFRT) will improve recovery for those with patellar instability.

Recruitment Criteria

Accepts Healthy Volunteers

Healthy volunteers are participants who do not have a disease or condition, or related conditions or symptoms

No
Study Type

An interventional clinical study is where participants are assigned to receive one or more interventions (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes.


An observational clinical study is where participants identified as belonging to study groups are assessed for biomedical or health outcomes.


Searching Both is inclusive of interventional and observational studies.

Interventional
Eligible Ages 14 Years - 40 Years
Gender All
More Inclusion & Exclusion Criteria

Inclusion Criteria:

  • - Diagnosis of traumatic patellar instability (either primary or recurrent) determined by an American Board of Family Medicine certified physician with a Certificate of Added Qualifications in Sports Medicine or licensed Physical Therapist utilizing clinical examination, radiographic imaging, and patients' reports of instability.
  • - Age 14 to 40 years.
  • - Skeletally mature with closed growth plates visualized by radiograph.
  • - A score of 80 or more on the Sports Activity Scale, which corresponds to participating in "running, twisting, turning (tennis, racquetball, handball, ice hockey, field hockey, skiing, wrestling)" at least 1-3 times per week.
  • - Desire to resume pre-injury activity level.

Exclusion Criteria:

  • - Concomitant osteochondral lesion requiring surgical fixation.
  • - Radiographic evidence of osteoarthritis (< Kellgren-Lawrence Grade 2) - Previous ipsilateral or contralateral knee surgery.
  • - Most recent instability event more than 3 months before enrollment.
  • - History of any inflammatory disorder.
  • - BMI > 35 kg/m2.
  • - Diabetes or uncontrolled hypertension.
  • - Varicose veins or a history of personal or immediate family history (parental or sibling) of deep vein thrombosis.
  • - Pre-existing conditions or previous surgeries that effect the ability to walk.
- Planned trips or vacations that will result in the inability to attend 4 consecutive physical therapy sessions

Trial Details

Trial ID:

This trial id was obtained from ClinicalTrials.gov, a service of the U.S. National Institutes of Health, providing information on publicly and privately supported clinical studies of human participants with locations in all 50 States and in 196 countries.

NCT04554212
Phase

Phase 1: Studies that emphasize safety and how the drug is metabolized and excreted in humans.

Phase 2: Studies that gather preliminary data on effectiveness (whether the drug works in people who have a certain disease or condition) and additional safety data.

Phase 3: Studies that gather more information about safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs.

Phase 4: Studies occurring after FDA has approved a drug for marketing, efficacy, or optimal use.

N/A
Lead Sponsor

The sponsor is the organization or person who oversees the clinical study and is responsible for analyzing the study data.

Caitlin Conley
Principal Investigator

The person who is responsible for the scientific and technical direction of the entire clinical study.

Caitlin Conley, PhD
Principal Investigator Affiliation University of Kentucky
Agency Class

Category of organization(s) involved as sponsor (and collaborator) supporting the trial.

Other
Overall Status Recruiting
Countries United States
Conditions

The disease, disorder, syndrome, illness, or injury that is being studied.

Patellar Dislocation, Knee Injuries, Leg Injury, Wounds and Injuries
Additional Details

Participants will randomly be assigned to 1 of 2 groups. This means that neither the participant or their doctor will not choose the treatment, but that the treatment will be randomly selected (like a coin toss). The study treatments is blood flow restriction training (BFRT). BFRT uses an air cuff that is inflated around the top of the thigh. This temporarily limits blood flow to the muscles and may allow the participant to recover strength more quickly after injury. As will be described later, the participant will be closely monitored during all study treatments to make sure they are as safe as possible. The two groups that participants could be assigned to are: 1. Standard physical therapy. 2. Standard physical therapy and BFRT.Physical Therapy Sessions: We are comparing two physical therapy interventions, one is the standard of care and the other is the standard of care plus an additional treatment. Participants have a 50/50 chance of receiving either treatment. If randomized to receive BFRT, the air cuffs will then be placed on the participants' thighs and they will be doing a standardized exercise program that will vary depending on the stage of rehabilitation they are in and as determined by the study personnel. Participants will also complete a standardized course of physical therapy. Activities in physical therapy may include ice over the knee, range of motion exercises to maintain hip strength and gait training exercises as needed. The following procedures may be performed. Some procedures may not be performed due to time constraints, availability of equipment, and/or by the decision of the investigator. Before initiating physical therapy, participants will be asked some questions including but not limited to the following: age, sex, level of activities, and expectations. Participants will also complete a Sports Activity Scale to determine their physical activity level. Timeline of Study Visits: Visit 1 Screening and enrollment: Upon arriving at the clinic or Biomotion Laboratory, potential subjects will have the following assessments: range of motion and knee instability, both of which are the standard of care for a patient with a suspected patellar instability. After providing informed consent to participate in the study, we will ask you to provide a urine sample and will collect about 2 teaspoons of blood for laboratory testing. The blood will be collected from your arm using standard venipuncture. In addition, we will ask you questions about your medical history including current medications, demographic information, BMI, and smoking status. You will be asked to complete three study questionnaires: the Norwich Patella Instability Score which asks questions about your knee, the Cincinnati Occupational Rating Scale which asks questions about the physical demands of your job or daily life, and a Visual Analogue Scale that will ask you to rate your current pain. You will be randomized to either standard physical therapy or standard physical therapy with BFRT. You have a 50/50 chance of having BFRT. We will also schedule you to go to the BioMotion laboratory for baseline strength testing and to have your first study MRI at the MRISC. Visit 2 (1 week)

  • - Knee and Hip Strength.
  • - Walking Biomechanics.
  • - MRI.
Visit 3 (5 weeks)
  • - Knee and Hip Strength.
  • - Questionnaires.
Visit 4 (9 weeks)
  • - Lab specimens collected (urine and about 2 teaspoons of blood) - Knee and Hip Strength.
  • - Walking Biomechanics.
  • - Questionnaires.
Visit 5 (6 months)
  • - Lab specimens collected (urine and about 2 teaspoons of blood) - Knee and Hip Strength.
  • - Walking and Running Biomechanics.
  • - Questionnaires.
Visit 6 (1 year)
  • - Lab specimens collected (urine and about 2 teaspoons of blood) - Knee and Hip Strength.
  • - Walking, Running, and Jumping Biomechanics.
  • - Questionnaires.
  • - MRI.
Visit 7 (2 years)
  • - Lab specimens collected (urine and about 2 teaspoons of blood) - Knee and Hip Strength.
  • - Walking, Running, and Jumping Biomechanics.
  • - Questionnaires.
- MRI

Arms & Interventions

Arms

Active Comparator: Standard Physical Therapy with Sham BFRT

Participants will undergo 8 weeks of sham blood flow restriction training with cuff inflated to less than 10% occlusion.

Active Comparator: Standard Physical Therapy with BFRT

Participants will undergo 8 weeks of blood flow restriction training with cuff inflated to 60% occlusion.

Interventions

Device: - Blood Flow Restriction Training

Participants will undergo 8 weeks of blood flow restriction training with cuff inflated to 60% occlusion.

Device: - Sham Blood Flow Restriction Training

Participants will undergo 8 weeks of sham blood flow restriction training with cuff inflated to less than 10% occlusion.

Contact a Trial Team

If you are interested in learning more about this trial, find the trial site nearest to your location and contact the site coordinator via email or phone. We also strongly recommend that you consult with your healthcare provider about the trials that may interest you and refer to our terms of service below.

UK Healthcare at Turfland, Lexington, Kentucky

Status

Recruiting

Address

UK Healthcare at Turfland

Lexington, Kentucky, 40504

Site Contact

Caitlin Conley, PhD

[email protected]

859-257-1939

Lexington, Kentucky

Status

Recruiting

Address

University of Kentucky Biomotion Laboratory

Lexington, Kentucky, 40536

Site Contact

Brian Noehren, PhD, PT

[email protected]

859-218-0581

Foxboro, Massachusetts

Status

Recruiting

Address

Center for Sports Performance and Research

Foxboro, Massachusetts, 02035

Site Contact

Molly Zgoda

[email protected]

508-216-1145

Foxboro Sports Medicine Clinic, Foxboro, Massachusetts

Status

Recruiting

Address

Foxboro Sports Medicine Clinic

Foxboro, Massachusetts, 02035

Site Contact

Cale Jacobs, PhD

[email protected]

508-216-1145